Home LiteratureArticle Details
PMID: 19436756 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy.

PloS one ·Vol. 4 ·No. 5 ·2009-00-00 ·Pages e5515

Xilouri M, Vogiatzi T, Vekrellis K, Park D, Stefanis L

Abstract

The mechanisms through which aberrant alpha-synuclein (ASYN) leads to neuronal death in Parkinson's disease (PD) are uncertain. In isolated liver lysosomes, mutant ASYNs impair Chaperone Mediated Autophagy (CMA), a targeted lysosomal degradation pathway; however, whether this occurs in a cellular context, and whether it mediates ASYN toxicity, is unknown. We have investigated presently the effects of WT or mutant ASYN on the lysosomal pathways of CMA and macroautophagy in neuronal cells and assessed their impact on ASYN-mediated toxicity. Novel inducible SH-SY5Y and PC12 cell lines expressing human WT and A53T ASYN, as well as two mutant forms that lack the CMA-targeting motif were generated. Such forms were also expressed in primary cortical neurons, using adenoviral transduction. In each case, effects on long-lived protein degradation, LC3 II levels (as a macroautophagy index), and cell death and survival were assessed. In both PC12 and SH-SY5Y cycling cells, induction of A53T ASYN evoked a significant decrease in lysosomal degradation, largely due to CMA impairment. In neuronally differentiated SH-SH5Y cells, both WT and A53T ASYN induction resulted in gradual toxicity, which was partly dependent on CMA impairment and compensatory macroautophagy induction. In primary neurons both WT and A53T ASYN were toxic, but only in the case of A53T ASYN did CMA dysfunction and compensatory macroautophagy induction occur and participate in death. Expression of mutant A53T, and, in some cases, WT ASYN in neuronal cells leads to CMA dysfunction, and this in turn leads to compensatory induction of macroautophagy. Inhibition of these lysosomal effects mitigates ASYN toxicity. Therefore, CMA dysfunction mediates aberrant ASYN toxicity, and may be a target for therapeutic intervention in PD and related disorders. Furthermore, macroautophagy induction in the context of ASYN over-expression, in contrast to other settings, appears to be a detrimental response, leading to neuronal death.

MeSH Terms
Animals Autophagy Cell Line Down-Regulation Humans Lysosomes/metabolism Molecular Chaperones/metabolism Neurons/metabolism PC12 Cells Parkinson Disease/metabolism RNA, Small Interfering/metabolism Rats alpha-Synuclein/genetics,metabolism,toxicity
Chemicals
Molecular Chaperones RNA, Small Interfering alpha-Synuclein
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Xilouri Maria
Division of Basic Neurosciences, Biomedical Research Foundation of the Academy of Athens, Athens, Greece.
Vogiatzi Tereza
Vekrellis Kostas
Park David
Stefanis Leonidas
References (64)
64 references, click to expand
  1. Alpha-synuclein and Parkinson's disease.
    Cell Mol Life Sci. 2000 Dec;57(13-14):1894-908 PMID: 11215516
  2. Parkinson's disease alpha-synuclein mutations exhibit defective axonal transport in cultured neurons.
    J Cell Sci. 2004 Mar 1;117(Pt 7):1017-24 PMID: 14996933
  3. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8 PMID: 12122208
  4. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.
    Annu Rev Neurosci. 2003;26:267-98 PMID: 12704221
  5. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice.
    Nature. 2006 Jun 15;441(7095):885-9 PMID: 16625204
  6. Cell-produced alpha-synuclein oligomers are targeted to, and impair, the 26S proteasome.
    Neurobiol Aging. 2010 Jun;31(6):953-68 PMID: 18715677
  7. Autophagy: dual roles in life and death?
    Nat Rev Mol Cell Biol. 2005 Jun;6(6):505-10 PMID: 15928714
  8. A receptor for the selective uptake and degradation of proteins by lysosomes.
    Science. 1996 Jul 26;273(5274):501-3 PMID: 8662539
  9. Lysosomes and autophagy in cell death control.
    Nat Rev Cancer. 2005 Nov;5(11):886-97 PMID: 16239905
  10. Autophagy and cell death in model organisms.
    Cell Death Differ. 2009 Jan;16(1):21-30 PMID: 19079286
  11. Autophagy: in sickness and in health.
    Trends Cell Biol. 2004 Feb;14(2):70-7 PMID: 15102438
  12. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.
    Science. 2004 Aug 27;305(5688):1292-5 PMID: 15333840
  13. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.
    Science. 1997 Jun 27;276(5321):2045-7 PMID: 9197268
  14. Pathophysiology of chaperone-mediated autophagy.
    Int J Biochem Cell Biol. 2004 Dec;36(12):2420-34 PMID: 15325582
  15. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease.
    Science. 2005 Feb 25;307(5713):1282-8 PMID: 15731448
  16. alpha-Synuclein locus triplication causes Parkinson's disease.
    Science. 2003 Oct 31;302(5646):841 PMID: 14593171
  17. Neurobiology of alpha-synuclein.
    Mol Neurobiol. 2004 Aug;30(1):1-21 PMID: 15247485
  18. Mechanisms of chaperone-mediated autophagy.
    Int J Biochem Cell Biol. 2004 Dec;36(12):2435-44 PMID: 15325583
  19. Rational siRNA design for RNA interference.
    Nat Biotechnol. 2004 Mar;22(3):326-30 PMID: 14758366
  20. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.
    Lancet. 2004 Sep 25-Oct 1;364(9440):1169-71 PMID: 15451225
  21. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?
    Brain Res Mol Brain Res. 2005 Mar 24;134(1):18-23 PMID: 15790526
  22. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.
    Nat Genet. 1998 Feb;18(2):106-8 PMID: 9462735
  23. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.
    Lancet. 2004 Sep 25-Oct 1;364(9440):1167-9 PMID: 15451224
  24. Caspase-dependent and -independent death of camptothecin-treated embryonic cortical neurons.
    J Neurosci. 1999 Aug 1;19(15):6235-47 PMID: 10414953
  25. Inhibitors of trypsin-like serine proteases inhibit processing of the caspase Nedd-2 and protect PC12 cells and sympathetic neurons from death evoked by withdrawal of trophic support.
    J Neurochem. 1997 Oct;69(4):1425-37 PMID: 9326271
  26. Autophagy in neurodegeneration and development.
    Biochim Biophys Acta. 2008 Dec;1782(12):723-9 PMID: 18644437
  27. Autophagy and signaling: their role in cell survival and cell death.
    Cell Death Differ. 2005 Nov;12 Suppl 2:1509-18 PMID: 16247498
  28. Multiple agents rescue PC12 cells from serum-free cell death by translation- and transcription-independent mechanisms.
    J Neurosci. 1991 Aug;11(8):2552-63 PMID: 1714494
  29. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.
    Proc Natl Acad Sci U S A. 1998 May 26;95(11):6469-73 PMID: 9600990
  30. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.
    Nature. 2001 May 24;411(6836):494-8 PMID: 11373684
  31. Development by self-digestion: molecular mechanisms and biological functions of autophagy.
    Dev Cell. 2004 Apr;6(4):463-77 PMID: 15068787
  32. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.
    Nature. 2007 Jun 14;447(7146):859-63 PMID: 17568747
  33. Alpha-synuclein in Lewy bodies.
    Nature. 1997 Aug 28;388(6645):839-40 PMID: 9278044
  34. Staging of brain pathology related to sporadic Parkinson's disease.
    Neurobiol Aging. 2003 Mar-Apr;24(2):197-211 PMID: 12498954
  35. Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination.
    Mol Cell Neurosci. 2002 Oct;21(2):223-38 PMID: 12401444
  36. Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death.
    Am J Pathol. 2007 Jan;170(1):75-86 PMID: 17200184
  37. Alpha-synuclein overexpression increases cytosolic catecholamine concentration.
    J Neurosci. 2006 Sep 6;26(36):9304-11 PMID: 16957086
  38. Loss of autophagy in the central nervous system causes neurodegeneration in mice.
    Nature. 2006 Jun 15;441(7095):880-4 PMID: 16625205
  39. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.
    J Neurochem. 2008 May;105(3):1048-56 PMID: 18182054
  40. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
    Science. 2000 Nov 3;290(5493):985-9 PMID: 11062131
  41. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models.
    Science. 2006 Jul 21;313(5785):324-8 PMID: 16794039
  42. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.
    Ann Neurol. 2004 Feb;55(2):164-73 PMID: 14755719
  43. Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease.
    J Alzheimers Dis. 2006;9(3 Suppl):277-89 PMID: 16914867
  44. Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations.
    J Biol Chem. 2005 Jun 3;280(22):21212-9 PMID: 15817478
  45. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.
    J Neurosci. 2002 Apr 1;22(7):2780-91 PMID: 11923443
  46. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.
    J Clin Invest. 2008 Feb;118(2):777-88 PMID: 18172548
  47. Autophagy in neuroprotection and neurodegeneration: A question of balance.
    Future Neurol. 2008 May;3(3):309-323 PMID: 18806889
  48. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death.
    J Neurosci. 2001 Dec 15;21(24):9549-60 PMID: 11739566
  49. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.
    JAMA. 2006 Aug 9;296(6):661-70 PMID: 16896109
  50. Lack of p53 delays apoptosis, but increases ubiquitinated inclusions, in proteasomal inhibitor-treated cultured cortical neurons.
    Mol Cell Neurosci. 2003 Oct;24(2):430-41 PMID: 14572464
  51. Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy.
    Science. 2009 Jan 2;323(5910):124-7 PMID: 19119233
  52. Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo.
    J Neurosci. 2007 Mar 21;27(12):3338-46 PMID: 17376994
  53. Neuroprotective actions of dipyridamole on cultured CNS neurons.
    J Neurosci. 1998 Jul 15;18(14):5112-23 PMID: 9651195
  54. Autophagy and its possible roles in nervous system diseases, damage and repair.
    Autophagy. 2005 Apr;1(1):11-22 PMID: 16874045
  55. Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila.
    PLoS One. 2009;4(1):e4201 PMID: 19145255
  56. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    J Neurochem. 2008 Oct;107(2):303-16 PMID: 18691382
  57. A simplified system for generating recombinant adenoviruses.
    Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2509-14 PMID: 9482916
  58. Parkinson's disease: mechanisms and models.
    Neuron. 2003 Sep 11;39(6):889-909 PMID: 12971891
  59. Consequences of the selective blockage of chaperone-mediated autophagy.
    Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5805-10 PMID: 16585521
  60. 3,4-dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinson's disease.
    Curr Drug Targets CNS Neurol Disord. 2003 Apr;2(2):143-8 PMID: 12769806
  61. Autophagy in neurodegenerative disease: friend, foe or turncoat?
    Trends Neurosci. 2006 Sep;29(9):528-35 PMID: 16859759
  62. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
    Neurobiol Dis. 2007 Jan;25(1):134-49 PMID: 17055279
  63. Alpha-Synuclein is degraded by both autophagy and the proteasome.
    J Biol Chem. 2003 Jul 4;278(27):25009-13 PMID: 12719433
  64. Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells.
    J Biol Chem. 2008 Aug 29;283(35):23542-56 PMID: 18566453
Article Info
Journal
PloS one
Abbr.
PLoS One
ISSN
1932-6203
Published
2009-00-00
Epub
2009-00-13
Pages
e5515
Language
English
Region
United States
NLM ID
101285081
PMCID
PMC2677735
Subset
IM
Grants
NINDS NIH HHS · R21 NS055693 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com